In spite of the importance of IGF-I for growth and development, knowledge about regulation of its production in submammalian species is rather limited. In order to create a tool for investigation of direct regulatory effects on the expression of IGF-I in bony fish liver, a primary cell culture of hepatocytes from Oreochromis mossambicus, the tilapia, was established. The cells were viable for up to 3 days and IGF-I mRNA synthesis was detected by northern blot and semiquantitative reverse transcriptase (RT)-PCR. Northern blot analysis of the primary cultured hepatocytes revealed four different IGF-I transcripts, 0·5, 1·9, 3·9 and 6·0 kb in size, which were identical to those in liver tissue. However, the expression rate was weaker than that in liver. The direct effects of recombinant tilapia (rt) growth hormone (GH) and salmon (s) IGF-I on the expression of IGF-I in primary cultured hepatocytes were investigated in time-course and doseresponse experiments. In untreated cultures, IGF-I mRNA decreased with time. Hepatocytes treated with 100 nM rtGH resulted in a pronounced stimulation of IGF-I mRNA expression throughout the experiment. Treatment with rtGH in concentrations ranging from 0·1 nM to 1 µM caused a clear dose-dependent increase in the amount of IGF-I mRNA. Significant stimulation was obtained even with 0·1 nM, reaching a plateau with 10 nM. Neither significant inhibitory nor stimulatory effects were detected by adding sIGF-I from 0·1 nM to 1 µM to the hepataocytes. Our results indicate that the established primary cell culture of tilapia hepatocytes is a useful system in which to study direct effects of potential regulators of bony fish liver cell function.
Introduction
Insulin-like growth factor-I (IGF-I) belongs to a family of polypeptides that have insulin-like metabolic and mitogenic properties. Human IGF-I consists of a basic single polypeptide chain of 70 amino acids and has a molecular mass of approximately 7·5 kDa. IGF-I sequences are highly conserved throughout evolution (Reinecke & Collet 1998) . IGF-I cDNA sequences have recently been characterised in several bony fish species: Oncorhynchus kisutch (Cao et al. 1989) , O. mykiss (Shamblott & Chen 1992) , Oreochromis mossambicus , Chen et al. 1998 , Cyprinus carpio (Hashimoto et al. 1997) , Cottus scorpius (Loffing-Cueni et al. 1998) and Lates calcarifer (Kinhult-Stahlbom et al. 1999) . These showed about 80% sequence homology to each other, and approximately 45% to the human IGF-I sequence.
It is generally accepted that liver is the main site of IGF-I production in mammals (Humbel 1990 ) and in lower vertebrates such as teleosts (Bern et al. 1991 , Siharath & Bern 1993 , Duan 1997 , 1998 , Reinecke 1997 . As in mammals, the IGF-system in fish contains three components: ligands (IGF-Is and -II), receptors (type I and type II) and IGF-binding proteins (IGFBPs) (Siharath & Bern 1993 , Duan 1997 . Recent studies have dealt also with the distribution of IGF-I in extrahepatic tissues of bony fish (Duan et al. 1993a , Duan et al. 1994 , Loffing-Cueni et al. 1998 , where it is believed to act in a paracrine/autocrine manner (Reinecke & Collet 1998) . Hepatic IGF-I mRNA has been identified by northern blot, RNase protection assay or in situ hybridisation in O. kisutch (Duguay et al. 1992) , Sparus aurata (Funkenstein et al. 1997) , Oreochromis mossambicus (Schmid et al. 1999) and Lates calcarifer (Kinhult-Stahlbom et al. 1999) .
In mammals, growth hormone (GH) directly stimulates the expression and secretion of IGF-I in liver (Daughaday & Rotwein 1989) . In hypophysectomised rats, a single injection of GH led to a 15-fold increase in liver IGF-I mRNA expression compared with untreated animals (Bichell et al. 1992) . Although few studies have dealt with the potential pituitary-GH-liver IGF-I axis in nonmammalians, there is indication that it may exist also in bony fish. GH binding sites have been detected in the liver of the eel (Hirano 1991) , salmonids (Gray et al. 1990 , Shamblott et al. 1995 , the tilapia (Fryer 1979 , Ng et al. 1992 and the barramundi (Kinhult-Stahlbom et al. 1999) . Evidence for a potential GH-dependency of liver IGF-I expression, however, is conflicting. In salmonids, injections of bovine GH increased IGF-I mRNA and serum IGF-I levels (Cao et al. 1989 , Shamblott et al. 1995 . In contrast, no significant increase in the amount of liver IGF-I mRNA was achieved after intraperitoneal administration of recombinant seabream GH in barramundi (Kinhult-Stahlbom et al. 1999) . In vitro studies, however, indicate that GH stimulates the expression of IGF-I mRNA expression in bony fish liver cell cultures. As with most studies on bony fish, these were performed in members of the small family of salmonids -Oncorhynchus kisutch (Duan et al. 1993a) , O. nerka (Duan et al. 1993b) and O. mykiss (Shamblott et al. 1995) -and data on other bony fish are lacking. Some investigations describe a dose-dependency of the GH-stimulated IGF-I mRNA expression in hepatocytes, but no information is available about its potential time-dependency in vitro.
In mammals, IGF-I receptors have been demonstrated in liver (McElduff et al. 1988 , Venkatesan & Davidson 1990 , liver plasma membranes and cell lines (Kasuga et al. 1981 , Venkatesan & Davidson 1990 . Although there is evidence that the mammalian hepatic IGF-I receptor is regulated by GH and the serum concentration of IGF-I (Venkatesan & Davidson 1990) , its physiological meaning is unknown. Similarly, an IGF-I receptor has recently been characterised in the liver of a bony fish, Lates calcarifer, the barramundi (Drakenberg et al. 1997) . Some in vivo studies in salmonids have indicated growth-promoting effects of infused IGF-I (McCormick et al. 1992 , McCormick 1996 , although no study has dealt with the potential effects of IGF-I on bony fish liver. In contrast, Skyrud et al. (1989) have demonstrated that weekly injections of human IGF-I (>1·0 µg/g) decreased the growth rate. In the striped bass, Fukazawa et al. (1995) have shown inhibitory effects of IGF-I on synthesis of IGFBPs-1 and -2 in vitro. This may reflect its functional role in the hepatic IGF system of fish.
The present study aimed to establish a primary liver cell culture of a non-salmonid bony fish. We carried out our investigations on the tilapia (Oreochromis mossambicus), which belongs to the largest order of vertebrates (Nelson 1984) , the perciformes. The tilapia has considerable commercial value in the aquaculture industry, and studies on the regulation of its growth may have an important impact in basic and applied science. The effects of recombinant tilapia (rt) GH (Rentier-Delrue et al. 1989 ) and salmon (s) IGF-I on the expression of IGF-I mRNA and the potential dose-and time-dependency of the GH and IGF-I treatments were studied in the primary tilapia hepatocyte culture, with analyses by northern blot and semiquantitative reverse transcriptase (RT)-PCR.
Materials and Methods

Materials
Mature individuals of Oreochromis mossambicus were bred at the Institute of Zoology II, University of Karlsruhe (Germany), kept in tap water at 24 C under a cycle of 12 h light-12 h darkness, and fed daily with a commercial protein diet (Fisch Fit, Fa. Interquell, Wehringen, Germany) . Dr Francoise Rentier-Delrue, University of Liège, Belgium kindly provided the recombinant tilapia growth hormone (rtGH). The sIGF-I was purchased from GroPep Pty Ltd (Adelaide, Australia). All chemicals were obtained from Sigma (Buchs, Switzerland) or as otherwise indicated. Primers were purchased from Intron (Kaltbrunn, Switzerland).
Methods
Isolation of hepatocytes
Livers of adult tilapias of approximately 100 g body weight were perfused in situ to isolate hepatocytes according to a modification of the method of Segner et al. (1993) . The animals were injected with a single dose of 3000 U heparin (Roche Diagnostics, Ingelheim, Germany) dissolved in 0·5 ml physiological saline, and anaesthetised by immersion in water containing 0·1% MS 222 (Sigma, Deisenhofen, Germany). A catheter (1 mm diameter) was introduced into the bulbus arteriosus and the liver perfused retrogradly with 100 ml calciummagnesium-free (CMF) medium (Table 1) to wash out the blood. The tissue was digested with 50 ml calciummagnesium containing (CMC) medium (Table 1) supplemented with collagenase D (0·5 mg/ml) (Roche 
All media were adjusted to pH 7·5 and 10 000 IU penicillin and 10 mg streptomycin per 100 ml medium were added after sterile filtration just before use. All chemicals were obtained from Sigma, except for amino acids, vitamins and glutamine, which were purchased from Serva.
Diagnostics, Ingelheim, Germany). The liver was exposed to the collagenase D for 15 min. Finally, the liver was perfused with 50 ml CMF medium, excised, transferred into ice-cold CMF medium and minced with scissors. The cells were selected by filtration through nylon gauzes with 250 and 50 µm meshes. Dispersed cells were washed and collected by three different centrifugation steps using ice-cold CMF medium (5 min at 70 g, 5 min at 50 g, and 5 min at 30 g). The supernatant was discarded each time and the final cell pellet resuspended in minimal essential medium (MEM) ( Table 1) . Cells were counted and the number of cells was adjusted to approximately 1·5 10 6 /ml MEM. Aliquots (1·5 ml) of cell suspension were seeded as a monolayer into sterile plastic Petri dishes (35 mm diameter) (Primaria, Falcon, Heidelberg, Germany). The cultures were incubated at 20 C under high humidity with normal air in an incubator (Heraeus, Hanau, Germany) and could be kept alive for up to 3 days.
Treatment of hepatocytes
As controls, the time courses of IGF-I mRNA expression were investigated in primary cultured hepatocytes kept in MEM without any further treatment for 42 h. Medium was replaced by fresh medium every 12 h. Every 6 h (0, 6, 12, 18, 24, 36, 42 h), medium was removed from two batches of Petri dishes and the cells were lysed in 500 µl RNA extraction buffer (ams, Lugano, Switzerland), and frozen on dry ice. Samples were stored at 80 C until required for further processing.
In order to study the effects of rtGH and of sIGF-I on IGF-I mRNA expression in tilapia hepatocytes, timecourse and dose-response experiments were performed. Every 12 h, medium was changed and cells were treated with either rtGH or sIGF-I. Therefore, the hepatocytes were exposed to the hormones continuously.
The rtGH dependence of IGF-I mRNA expression was examined in long time courses of 42 h in primary cultured hepatocytes treated with 100 nM rtGH. After 0, 6, 12, 18, 24, 36 and 42 h, the medium was discarded and hepatocytes were resuspended in 500 µl RNA extraction buffer. The cell suspension was frozen on dry ice and stored at 80 C. In addition, we examined the IGF-I mRNA signals after rtGH (100 nM) treatment during a short time course of 8 h. Samples were taken after 0·5, 1, 2, 3, 4, 5, 6 and 8 h and cells were lysed and stored as described above. The same schedule of long-and short-term experiments was accomplished with cultured hepatocytes treated with 10 nM sIGF-I.
The dose-dependence of rtGH and sIGF-I on the transcription rate of IGF-I in the primary cultured tilapia hepatocytes was studied after a 12-h incubation with rtGH or sIGF-I in concentrations ranging from 0·1 nM to 1 µM. After 12 h the medium was removed and the cells were lysed and frozen as described above.
Northern blot RNA samples were isolated by phenolchloroform extraction with the Ultraspec extraction system (ams, Lugano, Switzerland). Ten micrograms of RNA from primary hepatocytes cultured for 12 h and 2 µg RNA from freshly prepared liver tissue serving as a positive control were loaded on a 1% denaturating formaldehyde agarose gel in 1 3-(N-morpholino)-propane sulfonic acid (MOPS) (400 mM MOPS-NaOH-pH 7·0, 100 mM sodium acetate, 10 mM EDTA, 2% formaldehyde) and separated over a period of 4 h at 80 V. After the run, the gel was shaken twice in water for 10 min and equilibrated in 20 SSC for 20 min. Capillary transfer was carried out with 20 SSC for 20 h using a nylon membrane (Roche Diagnostics, Rotkreuz, Switzerland). Nucleic acids were fixed by u.v. cross linking (254 nm, 125 mJ). The membrane was prehybridised with DIG Easy Hyb buffer (Roche Diagnostics) for 1 h at 50 C. For hybridisation, the solution was replaced by an equal amount of DIG Easy Hyb containing 400 ng/ml digoxigenin-labelled IGF-I antisense cRNA probe specific for tilapia IGF-I, which was denatured at 85 C. The synthesis of the digoxigeninlabelled IGF-I probe is described elsewhere (Schmid et al. 1999) . After overnight incubation, the membrane was washed twice with 2 SSC, 0·1% SDS for 5 min at room temperature and twice with 0·1 SSC, 0·1% SDS for 20 min at 55 C. The alkaline-phosphatase-coupled antibody against digoxigenin was diluted 1:5000 in buffer 1 (100 mM maleic acid, 150 mM NaCl, pH 7·5) containing 1% blocking reagent (Roche Diagnostics) and the membrane was incubated for 30 min at room temperature. After a washing in buffer 1 for 15 min, the blot was treated with buffer 3 (100 mM Tris-HCl/pH 9·5, 100 mM NaCl, 50 mM MgCl 2 ) containing disodium 3-(4-methoxyspiro (1,2-dioxetane-3,2 -(5 -(chloro)tricyclodecan-4-yl (CSPD) (Roche Diagnostics) in a dilution of 1:100 for 15 min at room temperature in the dark and exposed on X-ray film for 5-30 min.
For standardisation, the blots were stripped with 100% formamide, 10 mM EDTA, 10 mM Tris-HCl/pH 8·0 for 2 h at 68 C, followed by washing with 0·1% SDS for 10 min at 100 C and rehybridised with a digoxigeninlabelled cRNA probe against actin. The intensity of the hybridisation signals was determined by scanning the optical density with a GelDoc 1000 (Bio-Rad, Glattbrugg, Switzerland).
Semiquantitative determination of the IGF-I signal using RT-PCR Total RNA was extracted as described above. For cDNA synthesis, 1 µg RNA was annealed with 1 µM of a poly (dT) primer (5 CCTGAATTCTAGAG CTCAT (dT17) 3 ) for 3 min at 70 C. The RNA/primer mix was incubated for 1 h at 37 C with 15 mM dNTPs and 10 units avian myeloblastosis virus (AMV)-RT (Pharmacia, Dübendorf, Switzerland) in 1 reaction buffer (50 mM Tris-HCl/pH 8·3, 40 mM KCl, 6 mM MgCl 2 ).
PCR was carried out with two specific primer pairs against tilapia IGF-I (sense: 5 GTCTGTGGAGAGCGA GGCTTT 3 , antisense 5 AACCTTGGGTGCTCTTG GCATG 3 ) ) and human actin (sense: 5 TGACGGGGTCACCCACACTGTGCCCA TCTA 3 , antisense: 5 CTAGAAGCATTGCGGTGG ACGATGGAGGG 3 ). The actin signal served as an internal standard in all experiments. Aliquots of cDNA (5 µl) were incubated with 1 µM IGF-I and actin sense and antisense primers, 200 µM dNTPs, and 1 unit Taqpolymerase (Pharmacia, Dübendorf, Switzerland) in 1 incubation buffer (10 mM Tris-HCl/pH 8·0, 50 mM KCl, 1·5 mM MgCl 2 , 0·001% gelatin). The amplification conditions were optimised to reach a linear PCR signal as follows: one cycle of 10 min at 94 C, 1 min at 59 C, 2 min at 72 C; 30 cycles of 1 min at 94 C, 1 min at 59 C and 2 min at 72 C, followed by a final extension of 5 min at 72 C (Stratagene RoboCycler Gradient 40). PCR fragments were separated on a 2% agarose gel and stained with ethidium bromide. The optical density was measured as described above. The actin signal was used for standardisation.
Stastistical analyses
Statistical evaluations were performed with ANOVA t-test for unpaired values and Wilcoxon test for paired values.
Results
General
Hepatocytes could be kept alive for up to 3 days; the integrity of the cells was verified with a microscope according to established methods (Segner et al. 1993) .
Northern blot analysis
For northern blot analysis of IGF-I expression, 10 µg RNA isolated from hepatocytes and 2 µg from liver were separated on a denaturating agarose gel and blotted onto a nylon membrane. Hybridisation with the specific digoxigenin-labelled IGF-I antisense cRNA probe revealed the same transcription products (sizes 0·5, 1·9, 3·9 and 6·0 kb) as were present in liver (Fig. 1) . However, the minor transcription products of size 0·5 and 6·0 kb were barely detectable in hepatocytes. In general, signals in cultured liver cells were weaker than those reflecting expression in liver, even after a threefold exposure time and use of a fivefold quantity of RNA.
IGF-I mRNA expression in untreated cell cultures
RT-PCR produced the expected IGF-I fragment of 207 bp and that for actin (661 bp). The sequences of both transcripts were determined (Microsynth, Balgach, Switzerland) and corresponded to those in the database. Isolated hepatocytes showed the maximal IGF-I mRNA expression at the onset of the experiments. The signal decreased with time, reaching 20% of the control after 42 h (Fig. 2a) . A marked reduction could already be observed after 6 h, when the IGF-I mRNA level was 75% of that in controls. Similar results were obtained during the short time course from 0·5 h to 8 h: the expression rate of IGF-I stayed nearly constant during the first 3 h, whereas after 4 h a distinct reduction was found (Fig. 3a) . The actin signals stayed relatively constant throughout the experiment and varied by a maximum of 20%.
Time dependency of IGF-I mRNA expression in rtGH-and sIGF-I-treated tilapia hepatocytes
Incubation of the liver cells with 100 nM rtGH produced greater IGF-I mRNA expression than was observed in untreated cells. The stimulatory effect of rtGH on IGF-I Figure 1 Northern blot analysis of IGF-I in liver (1) and hepatocytes (2). Four different IGF-I transcripts were detected, with sizes 6·0, 3·9, 1·9 and 0·5 kb. production in tilapia hepatocytes was time dependent (Fig. 2b) . After 6 h, the amount of IGF-I mRNA expression was increased to about 180% of the control value and remained high over 12 h. However, later on, the stimulated IGF-I mRNA levels decreased gradually, to reach about 100% of control after 42 h. In the short time-course experiments, the IGF-I signal was increased up to 150% by 30 min and reached its maximum (nearly 500% of the control) after 8 h (Fig. 3b) .
Treatment of the hepatocytes with 10 nM sIGF-I caused no significant differences in the IGF-I expression rate compared with that in untreated controls. In the long time-course studies, the amount of IGF-I mRNA was decreased to 85% of the onset level after 6 h and to 20% after 42 h (Fig. 2c) . In the short time-course experiments, no changes in IGF-I mRNA levels were detected during the first 4 h; however, the amount was slightly reduced after 6 h (Fig. 3c) .
Dose dependency of IGF-I mRNA expression in rtGH-and sIGF-I-treated tilapia hepatocytes
The increase in the amount of IGF-I mRNA after rtGH treatment was dose dependent (Fig. 4a) . Even a concentration of 0·1 nM caused a greater rate of IGF-I expression compared with that in untreated cells. Incubation of the hepatocytes with 10 nM rtGH increased the IGF-I mRNA level to a maximum of more than 200% of that in controls. Treatment with 100 nM and 1 µM rtGH did not cause further significant increases in the amount of IGF-I mRNA, indicating that the stimulation of IGF-I expression by rtGH had reached a plateau at 10 nM.
Treatment of the hepatocytes with increasing concentrations (0·1 nM to 1 µM) of sIGF-I had no effect on the IGF-I mRNA expression, even with concentrations as high as 1 µM sIGF-I (Fig. 4b) .
The statistical evaluation of the effects on IGF-I expression after treatment of tilapia hepatocytes with rtGH and sIGF-I is shown in Fig. 5 , which also compares the different IGF-I levels of expression in rtGH-and sIGF-Itreated cells.
Discussion
In this study, a primary cell culture of hepatocytes from the tilapia (Oreochromis mossambicus) was established. The cultured hepatocytes could be kept alive in good condition for up to 3 days, during which period the expression pattern of IGF-I mRNA was studied. To date, most studies dealing with the role of IGF-I in fish have been performed in vivo (Reinecke & Collet 1998) . However, in vivo results are often difficult to interpret because many physiological factors are involved and interfere with each other. Thus primary cell cultures are more suitable for physiological studies focusing on cellular mechanisms of particular effectors and excluding interactions of endogenous factors present in the intact animal.
Liver is the main site of IGF-I mRNA expression and peptide synthesis. Several studies have dealt with the regulation of liver IGF-I production in mammals, but much less is known in submammalian classes, including the bony fishes. IGF-I mRNA expression has been demonstrated in all hepatoma cell lines studied (Tsai et al. 1988) , in primary cultured hepatocytes in rat (e.g. Thissen et al. 1994 , Zhang et al. 1998 and in salmon (Duan et al. 1993a ,b, Shamblott et al. 1995 . In cultured rat hepatocytes, the transcription initiation for IGF-I was remarkably similar to that observed in liver in vivo (Krishna et al. 1996) , indicating that primary liver cell cultures are suitable for studies of the regulation of the hepatic IGF-I system.
Four IGF-I transcripts with sizes 0·5, 1·9, 3·9 and 6·0 kb have recently been detected in tilapia liver by northern blot analysis (Schmid et al. 1999) . The cultured tilapia hepatocytes showed transcription products of the same sizes, however, the intensity was weaker than in liver. Even after threefold exposure time, the rates of expression of the IGF-I signals in cultured liver cells were less than those of liver tissue. In particular, the 0·5 and 6·0 kb transcripts could barely be detected. These results are consistent with those obtained in cultured salmon (Duan et al. 1993b ) and rat (Zhang et al. 1998) hepatocytes, in which a decreased IGF-I mRNA stability has also been reported. As in those studies, we also used MEM to maintain the hepatocytes in culture. This might have caused reduced and product-specific expression rates throughout the IGF-I transcripts. In contrast to our results, in primary cultured hepatocytes of trout only the major IGF-I mRNA transcript sized 3·9 kb was detected (Duan et al. 1993b) . The probable reason for this discrepancy may be the more sensitive digoxigenin system that we used for northern blot analysis in the present study. The present results demonstrate that, in cultured hepatocytes, the same mRNA products are synthesised as in vivo. Thus our experimental model represents a useful tool with which to study the physiological interactions and hormonal regulation in tilapia liver in vitro.
For further experiments investigating the IGF-I expression pattern of cultured tilapia hepatocytes we used semiquantitative RT-PCR, because only small amounts of RNA are necessary and several incubations and treatments can be examined in parallel using the same cell culture. During short and long time-courses, the IGF-I mRNA level of the untreated cells decreased with time. This might indicate that IGF-I is produced in bony fish liver only under the influence of growth factors such as GH. These, of course, were absent from our serum-free medium. The levels of actin mRNA stayed relatively constant throughout the experiment, which demonstrates that the decline in IGF-I mRNA was specific. Our results are consistent with those of Duan & Plisetskaya (1993) , who demonstrated that fasting in salmon decreased hepatic IGF-I mRNA, whereas no significant changes occurred in a number of extrahepatic sites. In agreement with this, in primary cultured rat hepatocytes, amino acid deprivation resulted in reduced amounts of IGF-I mRNA during a time-course of 24 h (Thissen et al. 1994 ). This hypothesis is indirectly supported by our results obtained with rtGH-treated liver cells. Incubation of the hepatocytes with rtGH increased the amount of IGF-I mRNA in a time-and concentration-dependent manner. Six hours after administration of 100 nM rtGH, the amount of IGF-I mRNA was increased to more than 180%. Thus the GH receptors demonstrated in the liver of the tilapia (Fryer 1979 , Ng et al. 1992 are functional in our cell culture system. During the following hours, the IGF-I mRNA level diminished with time, but was still twofold greater at the end of the experiment compared with that in control cells. Similar results have been obtained in mammals: after incubation of primary cultured rat hepatocytes with GH, the expression of IGF-I mRNA was increased (Thissen et al. 1994) , suggesting that GH is necessary for the transcription of IGF-I mRNA in liver.
In salmonids, it has been shown that GH promotes IGF-I expression in liver , Duan et al. 1994 , Shamblott et al. 1995 . In agreement with this, GH has been found to increase plasma concentrations of IGF-I in gilthead seabream (Funkenstein et al. 1989) . These results are supported by those of the present in vitro study. In contrast, no significant change in hepatic IGF-I mRNA expression was obtained after intraperitoneal administration of recombinant seabream GH in barramundi (Kinhult-Stahlbom et al. 1999) . The conflicting results obtained in vivo might be caused by the different experimental conditions used. For example, repeated the GH injections eight-times, whereas Kinhult-Stahlbom et al. (1999) administered single injections.
The addition of rtGH to the tilapia hepatocytes resulted in a clear dose-dependent increase in IGF-I mRNA, starting at 1 nM and reaching a plateau at 10 nM. Similar results have been reported for primary cultured hepatocytes of salmonids. In rainbow trout hepatocytes, a clear dose-dependency of IGF-I expression was indicated after GH treatment, which was saturated at a concentration of about 100 nM (Shamblott et al. 1995) . Similarly, the expression of IGF-I mRNA in primary cultured hepatocytes of coho salmon was GH-dependent (Duan et al. 1993a) . GH treatment in concentrations between 500 nM and 50 µM resulted in five-to 10-fold greater expression rates compared with controls. These findings and the existence of GH receptors in tilapia liver suggest that GH is capable of stimulating IGF-I mRNA levels in tilapia hepatocytes, in vitro and in vivo. Thus in bony fish a pituitary-GH-liver IGF-I axis is present and active, as in mammals.
In mammals, the existence of hepatic IGF-I receptors has been demonstrated (e.g. Massague & Czech 1982 , McElduff et al. 1988 , Venkatesan & Davidson 1990 . The number of IGF-I receptors and their binding capacity are greater in fetal than in adult liver. Findings concerning the IGF-I binding ability in the liver of adult rat are contradictory. Kasuga et al. (1981) showed no IGF-I binding activity, whereas Venkatesan & Davidson (1990) detected distinct IGF-I binding. Furthermore, Raper et al. (1995) reported that IGF-I stimulates the proliferation of rat hepatocytes in cell culture. Recently, the presence of specific IGF-I receptors has also been demonstrated in the liver of a bony fish, the barramundi (Drakenberg et al. 1997) . Because no study has dealt with the physiological relevance of bony fish hepatic IGF-I receptors, we investigated the potential effects of sIGF-I on IGF-I expression in tilapia hepatocytes. In contrast to the clear stimulatory effect of rtGH, the administration of sIGF-I in concentrations ranging from 0·1 nM to 1 µM resulted in neither a stimulation nor an inhibition of IGF-I expression. Therefore, our results do not provide any evidence for effects of sIGF-I on IGF-I mRNA expression in cultured tilapia hepatocytes, and may indicate that no autocrine or paracrine actions of IGF-I are present in liver. However, because the IGF-I mRNA levels generally decreased with time in our system, potential inhibitory effects of IGF-I may not have been detected. Furthermore, one might speculate that IGF-I exerts no effects on adult tilapia liver, as has been shown in rat (Kasuga et al. 1981) .
In summary, we have established a useful in vitro tool with which to analyse direct effects of potential regulators of bony fish liver cell function. Our primary tilapia hepatocyte culture makes possible study of the influence of growth factors on IGF-I mRNA expression as indicated by the clear dose-and time-dependent effect of rtGH on the amount of IGF-I mRNA. A major advantage of this experimental model is the determination of direct effects of regulators of IGF-I mRNA expression without any interference by endogenous factors. The combination of primary hepatocyte culture methods and sensitive semiquantitative RT-PCR techniques for mRNA detection is the basis for current research on the influences of further potential factors (e.g. hormones and growth factors) on liver IGF-I mRNA expression in bony fish and the interactions of endogenous molecules (e.g. binding proteins).
